← Back to headlines
Eli Lilly Launches Lawsuit Against Six Firms Over Unapproved GLP-1 Drugs
Eli Lilly filed a lawsuit targeting six pharmaceutical companies for allegedly marketing unapproved weight-loss drugs, positioning itself to maintain dominance in the competitive GLP-1 market alongside rival Novo Nordisk.
24 Aug, 19:04 — 24 Aug, 19:04
Sources
Showing 1 of 1 sources
Related Stories
Shein Shares Plunge on Hong Kong Stock Exchange Debut Amid Growth Concerns
19m ago
South Korea Reports Record August Export Surge Driven by Semiconductor Demand
21m ago
South Korean and Turkish Defense Firms Climb Global Industry Rankings
24m ago
Apple Accuses OpenAI of Misusing Confidential Data and Spoliating Evidence
29m ago